NCT00387192View on ClinicalTrials.gov

A Study With OPTIVATE® in People With Von Willebrand Disease

PHASE3TerminatedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 30, 2006

Study Completion Date

September 30, 2008

Conditions
Von Willebrand Disease
Interventions
DRUG

Optivate

Plasma-derived Factor VIII

Trial Locations (4)

31096

Rambam Health Care Campus, 8 Haaliya St., Bat-Galim, Haifa

49100

Beilinson Hospital, Rabin Medical Center, 39 Jabontinsky Street, Petah Tikva

91120

Haddasah Ein-Karem Medical Center, P.O.Box 12000, Jerusalem

M13 9WL

University Department of Haematology, Manchester

Sponsors
All Listed Sponsors
lead

Bio Products Laboratory

OTHER